US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CEL-SCI Corp

0.2965

+0.00933.24%

Volume:1.23M

Turnover:363.22K

Market Cap:24.94M

PE:-0.62

High:0.3099

Open:0.2928

Low:0.2852

Close:0.2872

Loading ...

Overview Company News Filings

BRIEF-CEL-SCI Corp To File For Regulatory Approval Of Multikine In Saudi Arabia

CEL-SCI to File for Regulatory Approval of Multikine in Saudi Arabia—Pursuing Local Partnerships for Commercialization and Manufacturing to Serve Middle East and North Africa Market

CEL-SCI says publication supports strategy to seek early approval for multikine

New Study in the Scientific Journal "Cancer Cell" Supports CEL-SCI’s Strategy to Seek Early Approval for Multikine in Head and Neck Cancer Based on Pre-Surgical Tumor Responses

Experian plc EXPERIAN COMPLETES ACQUISITION OF CLEARSALE

BRIEF-CEL-SCI Reports New Data: Treatment with Multikine Resulted in up to 95% Improvement in Quality of Life for Head and Neck Cancer Patients

CEL-SCI Reports New Data: Treatment With Multikine Resulted in up to 95% Improvement in Quality of Life for Head and Neck Cancer Patients

THOMSON REUTERS

BRIEF-CEL-SCI announces closing of $2.5 million offering

CEL-SCI Announces Closing of $2.5 Million Offering

THOMSON REUTERS

CEL-SCI announces pricing of $2.56M common stock offering

CEL-SCI Announces Pricing of $2.5 Million Offering

THOMSON REUTERS

CEL-SCI Announces Pricing of $2.5 Million Offering

CEL-SCI’s Head and Neck Cancer Registration Study Protocol Clears FDA Review—in Talks With Potential Partners Interested in Commercialization of Multikine

THOMSON REUTERS

CEL-SCI’s Head and Neck Cancer Registration Study Protocol Clears FDA Review—in Talks with Potential Partners Interested in Commercialization of Multikine

Journal of the American Medical Association (JAMA) Study Provides Further Evidence that CEL-SCI’s Multikine Can Treat Unmet Need in ~70% of Head and Neck Patients Based on PD-L1 Expression

Brazilian Fintech Meliuz Unveils Bitcoin Reserve Strategy

Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Topical Rapamycin Formulations to Treat Rare Disease Indications

Brazil Shocks the Crypto World with First-Ever XRP Spot ETF Approval

Brazil Launches Innovative XRP ETF for Investors

Brazil Paves the Way for XRP ETF to Thrive in the Market

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CVM/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CVM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CVM\",,,,,undefined,":{"symbol":"CVM","market":"US","secType":"STK","nameCN":"CEL-SCI Corp","latestPrice":0.2965,"timestamp":1745524800000,"preClose":0.2872,"halted":0,"volume":1229132,"delay":0,"floatShares":82268700,"shares":84124041,"eps":-0.479643,"marketStatus":"Pre-Mkt","change":0.0093,"latestTime":"04-25 05:03:24 EDT","open":0.2928,"high":0.3099,"low":0.2852,"amount":363215.266226,"amplitude":0.086003,"askPrice":0.3256,"askSize":100,"bidPrice":0.2712,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.479643,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745587800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":433828800000,"exchange":"AMEX","adjPreClose":0.2965,"postHourTrading":{"tag":"盘后","latestPrice":0.2973,"preClose":0.2965,"latestTime":"19:43 EDT","volume":21936,"amount":6540.084,"timestamp":1745538216997},"volumeRatio":1.015176052172871,"impliedVol":1.8864,"impliedVolPercentile":0.759},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CVM\",,,,,undefined,":{"symbol":"CVM","floatShares":82268700,"roa":"-61.48%","roe":"-233.26%","lyrEps":-0.510314,"volumeRatio":1.015176052172871,"shares":84124041,"dividePrice":0,"high":0.3099,"amplitude":0.086003,"preClose":0.2872,"low":0.2852,"week52Low":0.18,"pbRate":"2.21","week52High":2.39,"institutionHeld":0.1743,"latestPrice":0.2965,"eps":-0.479643,"divideRate":0,"volume":1229132,"delay":0,"ttmEps":-0.479643,"open":0.2928,"prevYearClose":0.3999,"prevWeekClose":0.2548,"prevMonthClose":0.2304,"prevQuarterClose":0.2304,"fiveDayClose":0.2575,"twentyDayClose":0.24,"sixtyDayClose":0.435},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CVM\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529500518","title":"BRIEF-CEL-SCI Corp To File For Regulatory Approval Of Multikine In Saudi Arabia","url":"https://stock-news.laohu8.com/highlight/detail?id=2529500518","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529500518?lang=en_us&edition=fundamental","pubTime":"2025-04-23 20:36","pubTimestamp":1745411791,"startTime":"0","endTime":"0","summary":"BRIEF-CEL-SCI Corp To File For Regulatory Approval Of Multikine In Saudi ArabiaApril 23 (Reuters) - CEL-SCI Corp CVM.A:CEL-SCI CORP - TO FILE FOR REGULATORY APPROVAL OF MULTIKINE IN SAUDI ARABIASource text: ID:nBw2CdPCgaFurther company coverage: CVM.A ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nFWN3R11UV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2529509683","title":"CEL-SCI to File for Regulatory Approval of Multikine in Saudi Arabia—Pursuing Local Partnerships for Commercialization and Manufacturing to Serve Middle East and North Africa Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2529509683","media":"Business Wire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529509683?lang=en_us&edition=fundamental","pubTime":"2025-04-23 20:30","pubTimestamp":1745411400,"startTime":"0","endTime":"0","summary":"Concluded a successful meeting with Saudi Food and Drug Authority. CEL-SCI was encouraged to apply for Conditional Approval with Breakthrough Therapy Designation based on data from its concluded Phase 3 study. Evaluating Saudi Arabia-based partnerships to potentially fund local manufacturing and launch Multikine throughout the region. Based on discussions with the SFDA, CEL-SCI is preparing to submit a regulatory filing for the approval of Multikine as a neoadjuvant  treatment of newly diagnosed previously untreated locally advanced head and neck cancer. The submission will be made based on all data from CEL-SCI’s concluded 928-patient randomized controlled Phase 3 study and is expected to be filed as a Conditional Approval with Breakthrough Therapy designation. The SFDA’s usual response time for a complete submission for such an application is thought to be approximately 60 days after filing.The incidence of head and neck cancer in the MENA region is expected to double by 2030, from i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cel-sci-file-regulatory-approval-123000753.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4596","CVM","BK4516","BK4600","GCC","STRK","BK4023","BK4588","BK4139","BK4595","BK4585"],"gpt_icon":1},{"id":"2525813497","title":"CEL-SCI says publication supports strategy to seek early approval for multikine","url":"https://stock-news.laohu8.com/highlight/detail?id=2525813497","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525813497?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:55","pubTimestamp":1744120525,"startTime":"0","endTime":"0","summary":"CEL-SCI (CVM) announced that a study titled “Distinct CD8+ T cell dynamics associate with response to neoadjuvant cancer immunotherapies” by Li Hou...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cel-sci-says-publication-supports-strategy-to-seek-early-approval-for-multikine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cel-sci-says-publication-supports-strategy-to-seek-early-approval-for-multikine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2525813225","title":"New Study in the Scientific Journal \"Cancer Cell\" Supports CEL-SCI’s Strategy to Seek Early Approval for Multikine in Head and Neck Cancer Based on Pre-Surgical Tumor Responses","url":"https://stock-news.laohu8.com/highlight/detail?id=2525813225","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525813225?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:51","pubTimestamp":1744120260,"startTime":"0","endTime":"0","summary":"Head and neck cancer patients treated with Multikine who had complete or partial tumor responses before surgery had improvements in overall survival, suggesting pre-surgical tumor response is a strong indicator of efficacy and leads to improved overall survival. A third-party head and neck cancer study published in \"Cancer Cell\" confirms the observation that pre-surgical tumor responses in head and neck cancer leads to improved survival. As a neoadjuvant therapy, Multikine is given to patients right after diagnosis, prior to surgery. In the Phase 3 study, pre-surgery objective early tumor response to treatment with Multikine was confirmed by pathology at surgery. There were 45 objective early responders, of which 5 were complete pathological responders, whose t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/study-scientific-journal-cancer-cell-135100894.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","STRK","BK4596","CVM","BK4600","BK4595","BK4588","BK4139","BK4023","BK4516"],"gpt_icon":1},{"id":"2524482613","title":"Experian plc EXPERIAN COMPLETES ACQUISITION OF CLEARSALE","url":"https://stock-news.laohu8.com/highlight/detail?id=2524482613","media":"Dow Jones","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524482613?lang=en_us&edition=fundamental","pubTime":"2025-04-02 14:00","pubTimestamp":1743573600,"startTime":"0","endTime":"0","summary":"2 April 2025 - Further to our announcement on 4 October 2024, we are delighted to announce that all conditions related to the acquisition of ClearSale S.A. , the leading digital fraud prevention provider in Brazil have been satisfied and the transaction has completed .This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Author","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXPGY","CVM","BK4123","BK4139"],"gpt_icon":0},{"id":"2521729361","title":"BRIEF-CEL-SCI Reports New Data: Treatment with Multikine Resulted in up to 95% Improvement in Quality of Life for Head and Neck Cancer Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2521729361","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521729361?lang=en_us&edition=fundamental","pubTime":"2025-03-24 21:09","pubTimestamp":1742821773,"startTime":"0","endTime":"0","summary":"BRIEF-CEL-SCI Reports New Data: Treatment with Multikine Resulted in up to 95% Improvement in Quality of Life for Head and Neck Cancer PatientsMarch 24 (Reuters) - CEL-SCI Corp CVM.A:CEL-SCI REPORTS N","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nTUA7KTRLR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2521726635","title":"CEL-SCI Reports New Data: Treatment With Multikine Resulted in up to 95% Improvement in Quality of Life for Head and Neck Cancer Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2521726635","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521726635?lang=en_us&edition=fundamental","pubTime":"2025-03-24 21:00","pubTimestamp":1742821203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nTUA7KTRLR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CVM"],"gpt_icon":0},{"id":"2520958412","title":"BRIEF-CEL-SCI announces closing of $2.5 million offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2520958412","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520958412?lang=en_us&edition=fundamental","pubTime":"2025-03-19 05:23","pubTimestamp":1742332991,"startTime":"0","endTime":"0","summary":"BRIEF-CEL-SCI announces closing of $2.5 million offeringMarch 18 (Reuters) - CEL-SCI Corp CVM.A:CEL-SCI ANNOUNCES CLOSING OF $2.5 MILLION OFFERINGSource text: ID:nBwBq9mXaFurther company coverage: CVM.A ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nTUA96D8MM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2520931977","title":"CEL-SCI Announces Closing of $2.5 Million Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2520931977","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520931977?lang=en_us&edition=fundamental","pubTime":"2025-03-19 04:05","pubTimestamp":1742328302,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nTUA96D8MM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2520507131","title":"CEL-SCI announces pricing of $2.56M common stock offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2520507131","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520507131?lang=en_us&edition=fundamental","pubTime":"2025-03-18 03:35","pubTimestamp":1742240128,"startTime":"0","endTime":"0","summary":"CEL-SCI (CVM) Corporation announced the pricing of a best-efforts offering of 16M shares of its common stock. Total gross proceeds from the offerin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cel-sci-announces-pricing-of-2-56m-common-stock-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cel-sci-announces-pricing-of-2-56m-common-stock-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2520250269","title":"CEL-SCI Announces Pricing of $2.5 Million Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2520250269","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520250269?lang=en_us&edition=fundamental","pubTime":"2025-03-18 03:24","pubTimestamp":1742239442,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nTUA8KZY4P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2520507822","title":"CEL-SCI Announces Pricing of $2.5 Million Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2520507822","media":"Business Wire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520507822?lang=en_us&edition=fundamental","pubTime":"2025-03-18 03:24","pubTimestamp":1742239440,"startTime":"0","endTime":"0","summary":"VIENNA, Va., March 17, 2025----CEL-SCI Corporation  , a Phase 3 cancer immunotherapy company, today announced the pricing of a best-efforts offering of 16,000,000 shares of its common stock . Total gross proceeds from the offering, before deducting the placement agent’s fees and other offering expenses, are expected to be approximately $2,560,000. The offering is expected to close on March 18, 2025, subject to satisfaction of customary closing conditions.The Company intends to use the net proceeds from the offering to fund the continued development of Multikine, general corporate purposes, and working capital.Multikine , given right after diagnosis and before surgery, has been dosed in over 740 patients and received Orphan Drug designation from the FDA for neoadjuvant therapy in patients with squamous cell carcinoma  of the head and neck. Based on the data from the completed randomized controlled Phase 3 study, the FDA concurred with CEL-SCI’s target patient selection criteria and gave","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cel-sci-announces-pricing-2-192400115.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","CVM"],"gpt_icon":0},{"id":"2520540898","title":"CEL-SCI’s Head and Neck Cancer Registration Study Protocol Clears FDA Review—in Talks With Potential Partners Interested in Commercialization of Multikine","url":"https://stock-news.laohu8.com/highlight/detail?id=2520540898","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520540898?lang=en_us&edition=fundamental","pubTime":"2025-03-17 20:03","pubTimestamp":1742213001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nFWN3Q010E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2520528101","title":"CEL-SCI’s Head and Neck Cancer Registration Study Protocol Clears FDA Review—in Talks with Potential Partners Interested in Commercialization of Multikine","url":"https://stock-news.laohu8.com/highlight/detail?id=2520528101","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520528101?lang=en_us&edition=fundamental","pubTime":"2025-03-17 20:00","pubTimestamp":1742212800,"startTime":"0","endTime":"0","summary":"Growing body of data on PD-L1 as a cancer biomarker spurs interest. Working towards partnership for non-dilutive funding of the final confirmatory head and neck cancer Registration Study. CEL-SCI completed a randomized controlled Phase 3 study conducted in 928 locally advanced, resectable head and neck cancer stage 3 and 4a patients in 23 countries on 3 continents. The Phase 3 study demonstrated strong statistical results and improved survival with Multikine neoadjuvant treatment over control. The 5-year survival rate of the target patient population that will be treated in the confirmatory Registration Study increased to 73% when patients were treated with Multikine before standard of care vs 45% for control patients who received only the standard of care treatments. The survival advantage over control was accentuated in patients who had low to zero expression of PD-L1 on their tumors and had lower disease burden by having N0 (no nodal inv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cel-sci-head-neck-cancer-120000661.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4023","BK4613","CVM","BK4588","BK4528","SAP","BK4139"],"gpt_icon":0},{"id":"2519804117","title":"Journal of the American Medical Association (JAMA) Study Provides Further Evidence that CEL-SCI’s Multikine Can Treat Unmet Need in ~70% of Head and Neck Patients Based on PD-L1 Expression","url":"https://stock-news.laohu8.com/highlight/detail?id=2519804117","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519804117?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:30","pubTimestamp":1741955400,"startTime":"0","endTime":"0","summary":"The DEPEND study demonstrates that checkpoint inhibitor nivolumab  works best with high levels of PD-L1 biomarker, but does not work well with low levels of PD-L1. Multikine aims to address a major treatment gap for head and neck cancer patients where about 70% have low PD-L1 expression, in its upcoming confirmatory Registration Trial. \"With these latest findings published in JAMA, industry is taking notice. We believe there is growing interest in Multikine as an advanced clinical stage asset that can prolong life for about 70% of head and neck cancer patients whose tumors have low PD-L1 expression,\" stated CEL-SCI’s CEO Geert Kersten.The DEPEND Phase 2 data also confirm the independent findings reviewed by the FDA’s recent Oncologic Advisory Committee meeting  on the use of checkpoint inhibitors including blockbuster drugs nivolumab and pembrolizumab, which appear to not work well in patients with low PD-L1 expression. To CEL-SCI’s knowledge, Multikine is the only oncology drug with s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/journal-american-medical-association-jama-123000995.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4107","AFG","CVM","PD","BK4023","LU1169589451.USD","LU1169590202.USD","BK4117","BK4139"],"gpt_icon":0},{"id":"2517195476","title":"Brazilian Fintech Meliuz Unveils Bitcoin Reserve Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2517195476","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517195476?lang=en_us&edition=fundamental","pubTime":"2025-03-07 01:49","pubTimestamp":1741283392,"startTime":"0","endTime":"0","summary":"Meliuz, a Brazilian Fintech Company, has made a notable shift in diversifying its investments to feature Bitcoin. In a significant decision, Meliuz gave the nod to a new treasury strategy that would allow the company to set aside resources for Bitcoin  acquisition.According to the report, Meliuz has decided to seek long-term returns via Bitcoin. Hence, it will allow up to 10% of its cash to be invested in Bitcoin. Already, the company has made a significant purchase of 45.72 BTC for $4.1 million.Brazilian fintech unicorn Meliuz has adopted a Bitcoin treasury strategy, reportedly buying millions in BTC to maximize long-term shareholder value.#Bitcoin #Crypto #Meliuz #Brazilian. The initial 10% commitment from Meliuz could be increased to a higher percentage in the future. Notably, Meliuz’s board has called for a detailed analysis of this newly adopted approach and its profitability for the fintech firm.Given Brazil’s crypto-friendly atmosphere, there are speculations of possible digital","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/67c9e041325a5f5d96f1dfa4/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["BK4601","BK4596","BTC","FTVI","BK4600","BTC.USD.CC","ETH.USD.CC","STRK","ETH.USD.HKCC","BK4516","MSTR","BK4588","TON.USD.HKCC","BTC.USD.HKCC","APT.USD.HKCC","BK4595","BK4585","BK4594","TON.USD.CC","CVM","BK4139","IBIT","APT.USD.CC","BK4023","MSTU"],"gpt_icon":1},{"id":"2516673956","title":"Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Topical Rapamycin Formulations to Treat Rare Disease Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2516673956","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516673956?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:30","pubTimestamp":1741091400,"startTime":"0","endTime":"0","summary":"Target Indications Include Microcystic Lymphatic Malformations, Venous Malformations and AngiofibromasProprietary Invisicare Delivery Technology Designed to Optimize Local Skin Penetration Company Pla","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/04/3036382/0/en/Quoin-Pharmaceuticals-Files-U-S-and-International-Patent-Applications-for-Novel-Topical-Rapamycin-Formulations-to-Treat-Rare-Disease-Indications.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVM","BK4139","QNRX"],"gpt_icon":0},{"id":"2512904412","title":"Brazil Shocks the Crypto World with First-Ever XRP Spot ETF Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2512904412","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512904412?lang=en_us&edition=fundamental","pubTime":"2025-02-20 18:13","pubTimestamp":1740046401,"startTime":"0","endTime":"0","summary":"Brazil just made crypto history. The country’s securities regulator, Comissão de Valores Mobiliários (CVM), has officially approved the world’s fir...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/brazil-shocks-the-crypto-world-with-first-ever-xrp-spot-etf-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/brazil-shocks-the-crypto-world-with-first-ever-xrp-spot-etf-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4550","BK4588","CVM","FDN","BK4139","BK4585"],"gpt_icon":0},{"id":"2512499204","title":"Brazil Launches Innovative XRP ETF for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2512499204","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512499204?lang=en_us&edition=fundamental","pubTime":"2025-02-20 14:49","pubTimestamp":1740034163,"startTime":"0","endTime":"0","summary":"You can also read this news on BH NEWS: Brazil Launches Innovative XRP ETF for Investors. Brazil is set to make waves in the cryptocurrency sector with the approval of its first exchange-traded fund  that features XRP. The Brazilian Securities and Exchange Commission  has given the green light for this fund, managed by Hashdex, to be listed on B3, the nation’s primary stock exchange. While the official trading date is yet to be confirmed, this move represents a significant milestone in Brazil’s evolving market for digital currencies.The XRP ETF, scheduled for launch on December 10, 2024, is rooted in the coin’s real-world applications and the rising demand from institutional players. Managed by Genial Investimentos, this fund aims to offer investors a fresh option, diversifying the cryptocurrency investment landscape.– Brazil is embracing a flexible regulatory stance on cryptocurrency. – The XRP ETF’s approval reflects an accommodating investment climate. – There is a notable rise in i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/67b6d076562ecd3af918975c/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["FDN","BK4211","BK4550","ISBC","BK4139","BK4588","CVM","BK4585"],"gpt_icon":0},{"id":"2512249499","title":"Brazil Paves the Way for XRP ETF to Thrive in the Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2512249499","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512249499?lang=en_us&edition=fundamental","pubTime":"2025-02-20 14:49","pubTimestamp":1740034163,"startTime":"0","endTime":"0","summary":"You can also read this news on COINTURK NEWS: Brazil Paves the Way for XRP ETF to Thrive in the Market. The Brazilian Securities and Exchange Commission  has approved the first exchange-traded fund  that includes XRP. Managed by Hashdex, this fund will be listed on the country’s main stock exchange platform, B3. Although the official start date for trading has not been finalized, this development showcases Brazil’s innovative approach to the cryptocurrency market. Regulatory frameworks for cryptocurrency investments in Brazil are observed to be more flexible, in contrast to similar applications still under review in the United States.The establishment date for the XRP-based ETF has been set for December 10, 2024. The real-world utility of XRP and the increasing institutional demand played significant roles in the creation of this fund, managed by Genial Investimentos. With the XRP ETF, Hashdex aims to provide investors with a new alternative and enhance diversity within the cryptocurre","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/67b6d076562ecd3af918975e/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["BK4585","FDN","THAC","BK4550","CVM","BK4139","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":55,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CVM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-14","symbol":"CVM","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739509200000,"reportTimeType":"post","actualEps":-0.11},{"market":"US","date":"2025-01-13","symbol":"CVM","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1736744400000,"reportTimeType":"post","actualEps":-0.09},{"date":"2024-08-15","symbol":"CVM","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/06","expectedEps":-0.13,"defaultRemindTime":1723708800000,"name":null,"time":"Pre-Market","dateTimestamp":1723694400000,"actualEps":-0.14},{"date":"2024-05-15","symbol":"CVM","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715803200000,"name":null,"time":"Post Market","dateTimestamp":1715745600000,"actualEps":null},{"date":"2024-02-15","symbol":"CVM","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2023/12","expectedEps":null,"defaultRemindTime":1707987600000,"name":null,"time":"Pre-Market","dateTimestamp":1707973200000,"actualEps":-0.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CVM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CVM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1741665600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CVM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CVM","date":"2025-04-23","current":-0.821869,"percent":0.980519,"low":-36.303853,"twenty":-16.210733,"median":-4.072567,"eighty":-2.303265,"high":-0.528588,"avg":-8.218259,"sd":7.72603,"marketCap":22965863},"quantilePoints":[{"date":"2020-05-01","current":-21.240434,"twenty":-7.318328,"median":-2.479965,"eighty":-0.817762,"marketCap":614101360},{"date":"2020-05-08","current":-17.413353,"twenty":-7.318328,"median":-2.479965,"eighty":-0.817762,"marketCap":549078513},{"date":"2020-05-15","current":-18.738152,"twenty":-7.489378,"median":-2.479965,"eighty":-0.817762,"marketCap":590852135},{"date":"2020-05-22","current":-16.697245,"twenty":-7.601141,"median":-2.479965,"eighty":-0.817762,"marketCap":526498177},{"date":"2020-05-29","current":-15.909526,"twenty":-7.659518,"median":-2.479965,"eighty":-0.817762,"marketCap":501659807},{"date":"2020-06-05","current":-16.947883,"twenty":-7.762127,"median":-2.479965,"eighty":-0.817762,"marketCap":534401294},{"date":"2020-06-12","current":-15.420186,"twenty":-7.879311,"median":-2.479965,"eighty":-0.817762,"marketCap":486229910},{"date":"2020-06-19","current":-16.279515,"twenty":-7.985806,"median":-2.479965,"eighty":-0.817762,"marketCap":513326314},{"date":"2020-06-26","current":-18.189136,"twenty":-8.062403,"median":-2.479965,"eighty":-0.817762,"marketCap":573540544},{"date":"2020-07-02","current":-16.529405,"twenty":-8.151538,"median":-2.479965,"eighty":-0.817762,"marketCap":521205853},{"date":"2020-07-10","current":-17.470103,"twenty":-8.186901,"median":-2.479965,"eighty":-0.817762,"marketCap":550867974},{"date":"2020-07-17","current":-17.665573,"twenty":-8.266839,"median":-2.479965,"eighty":-0.817762,"marketCap":557031532},{"date":"2020-07-24","current":-16.236201,"twenty":-8.314192,"median":-2.479965,"eighty":-0.817762,"marketCap":511960516},{"date":"2020-07-31","current":-15.283286,"twenty":-8.342981,"median":-2.479965,"eighty":-0.817762,"marketCap":481913172},{"date":"2020-08-07","current":-14.892347,"twenty":-8.412596,"median":-2.479965,"eighty":-0.817762,"marketCap":469586056},{"date":"2020-08-14","current":-16.503475,"twenty":-8.470363,"median":-2.479965,"eighty":-0.817762,"marketCap":490912107},{"date":"2020-08-21","current":-16.555414,"twenty":-8.562705,"median":-2.479965,"eighty":-0.817762,"marketCap":492457071},{"date":"2020-08-28","current":-17.503292,"twenty":-8.806363,"median":-2.479965,"eighty":-0.817762,"marketCap":520652652},{"date":"2020-09-04","current":-17.607169,"twenty":-8.984749,"median":-2.479965,"eighty":-0.817762,"marketCap":523742579},{"date":"2020-09-11","current":-17.204646,"twenty":-9.06225,"median":-2.479965,"eighty":-0.817762,"marketCap":511769113},{"date":"2020-09-18","current":-18.619971,"twenty":-9.115153,"median":-2.479965,"eighty":-0.817762,"marketCap":553869364},{"date":"2020-09-25","current":-16.51646,"twenty":-9.194573,"median":-2.479965,"eighty":-0.817762,"marketCap":491298348},{"date":"2020-10-02","current":-17.620154,"twenty":-9.28401,"median":-2.479965,"eighty":-0.817762,"marketCap":524128819},{"date":"2020-10-09","current":-19.308157,"twenty":-9.372965,"median":-2.479965,"eighty":-0.817762,"marketCap":574340129},{"date":"2020-10-16","current":-20.80139,"twenty":-9.416922,"median":-2.479965,"eighty":-0.817762,"marketCap":618757825},{"date":"2020-10-23","current":-17.022861,"twenty":-9.659475,"median":-2.479965,"eighty":-0.817762,"marketCap":506361741},{"date":"2020-10-30","current":-15.665686,"twenty":-9.745942,"median":-2.479965,"eighty":-0.817762,"marketCap":465991240},{"date":"2020-11-06","current":-15.066665,"twenty":-9.920207,"median":-2.479965,"eighty":-0.817762,"marketCap":448172789},{"date":"2020-11-13","current":-16.499106,"twenty":-10.207212,"median":-2.479965,"eighty":-0.817762,"marketCap":490782129},{"date":"2020-11-20","current":-15.900085,"twenty":-10.500982,"median":-2.479965,"eighty":-0.817762,"marketCap":472963678},{"date":"2020-11-27","current":-16.850704,"twenty":-10.692293,"median":-2.479965,"eighty":-0.817762,"marketCap":501240786},{"date":"2020-12-04","current":-15.652664,"twenty":-11.010512,"median":-2.479965,"eighty":-0.817762,"marketCap":465603883},{"date":"2020-12-11","current":-19.339597,"twenty":-11.212214,"median":-2.482557,"eighty":-0.817762,"marketCap":575275353},{"date":"2020-12-18","current":-17.48182,"twenty":-12.418034,"median":-2.492735,"eighty":-0.817762,"marketCap":520013934},{"date":"2020-12-24","current":-17.120957,"twenty":-12.792988,"median":-2.500417,"eighty":-0.817762,"marketCap":509279701},{"date":"2020-12-31","current":-15.310637,"twenty":-13.515253,"median":-2.518522,"eighty":-0.817762,"marketCap":463559822},{"date":"2021-01-08","current":-18.25196,"twenty":-13.798902,"median":-2.526554,"eighty":-0.817762,"marketCap":552614196},{"date":"2021-01-15","current":-18.742981,"twenty":-14.056407,"median":-2.535735,"eighty":-0.817762,"marketCap":567480812},{"date":"2021-01-22","current":-18.716712,"twenty":-14.394355,"median":-2.535735,"eighty":-0.817762,"marketCap":566685464},{"date":"2021-01-29","current":-32.770663,"twenty":-14.574252,"median":-2.535735,"eighty":-0.817762,"marketCap":992196654},{"date":"2021-02-05","current":-30.984367,"twenty":-14.773602,"median":-2.535735,"eighty":-0.817762,"marketCap":938112989},{"date":"2021-02-12","current":-29.127713,"twenty":-14.836217,"median":-2.557047,"eighty":-0.817762,"marketCap":954464496},{"date":"2021-02-19","current":-24.539016,"twenty":-14.892347,"median":-2.570115,"eighty":-0.817762,"marketCap":804100875},{"date":"2021-02-26","current":-21.954009,"twenty":-14.992143,"median":-2.570115,"eighty":-0.817762,"marketCap":719394684},{"date":"2021-03-05","current":-24.019541,"twenty":-15.091995,"median":-2.57578,"eighty":-0.817762,"marketCap":787078578},{"date":"2021-03-12","current":-25.293492,"twenty":-15.193271,"median":-2.602518,"eighty":-0.817762,"marketCap":828823735},{"date":"2021-03-19","current":-21.892166,"twenty":-15.25121,"median":-2.616574,"eighty":-0.817762,"marketCap":717368220},{"date":"2021-03-26","current":-20.333741,"twenty":-15.328113,"median":-2.629256,"eighty":-0.818503,"marketCap":666301330},{"date":"2021-04-01","current":-20.370846,"twenty":-15.523478,"median":-2.642183,"eighty":-0.818503,"marketCap":667517208},{"date":"2021-04-09","current":-19.950319,"twenty":-15.637604,"median":-2.682036,"eighty":-0.817762,"marketCap":653737254},{"date":"2021-04-16","current":-21.607692,"twenty":-15.727789,"median":-2.952382,"eighty":-0.817762,"marketCap":708046486},{"date":"2021-04-23","current":-30.203768,"twenty":-15.842734,"median":-3.11969,"eighty":-0.817762,"marketCap":989724968},{"date":"2021-04-30","current":-29.845083,"twenty":-15.945112,"median":-3.220938,"eighty":-0.817762,"marketCap":977971478},{"date":"2021-05-07","current":-26.456126,"twenty":-16.001259,"median":-3.342026,"eighty":-0.817762,"marketCap":866921256},{"date":"2021-05-14","current":-27.618761,"twenty":-16.12622,"median":-3.420304,"eighty":-0.817762,"marketCap":905018777},{"date":"2021-05-21","current":-24.359361,"twenty":-16.194926,"median":-3.471932,"eighty":-0.817762,"marketCap":850039002},{"date":"2021-05-28","current":-25.215104,"twenty":-16.242394,"median":-3.499441,"eighty":-0.817762,"marketCap":879900815},{"date":"2021-06-04","current":-28.978027,"twenty":-16.27136,"median":-3.562279,"eighty":-0.817762,"marketCap":1011210978},{"date":"2021-06-11","current":-27.068328,"twenty":-16.313109,"median":-3.626813,"eighty":-0.817762,"marketCap":944570533},{"date":"2021-06-18","current":-27.019578,"twenty":-16.463579,"median":-3.656855,"eighty":-0.817762,"marketCap":942869371},{"date":"2021-06-25","current":-30.566127,"twenty":-16.539276,"median":-3.704254,"eighty":-0.817762,"marketCap":1066628950},{"date":"2021-07-02","current":-9.859342,"twenty":-16.554579,"median":-3.81599,"eighty":-0.817762,"marketCap":344049473},{"date":"2021-07-09","current":-10.888143,"twenty":-16.554579,"median":-3.886922,"eighty":-0.817762,"marketCap":379950287},{"date":"2021-07-16","current":-9.712371,"twenty":-16.554579,"median":-3.975297,"eighty":-0.817762,"marketCap":338920785},{"date":"2021-07-23","current":-9.40618,"twenty":-16.554579,"median":-4.078552,"eighty":-0.817762,"marketCap":328236019},{"date":"2021-07-30","current":-9.834847,"twenty":-16.554579,"median":-4.143086,"eighty":-0.817762,"marketCap":343194691},{"date":"2021-08-06","current":-11.231077,"twenty":-16.554579,"median":-4.233433,"eighty":-0.817762,"marketCap":391917226},{"date":"2021-08-13","current":-11.466148,"twenty":-16.554579,"median":-4.310874,"eighty":-0.817762,"marketCap":388544194},{"date":"2021-08-20","current":-12.10104,"twenty":-16.554579,"median":-4.432946,"eighty":-0.817762,"marketCap":410058269},{"date":"2021-08-27","current":-13.700968,"twenty":-16.554579,"median":-4.607581,"eighty":-0.817762,"marketCap":464273738},{"date":"2021-09-03","current":-14.615212,"twenty":-16.554579,"median":-4.744934,"eighty":-0.817762,"marketCap":495254006},{"date":"2021-09-10","current":-14.577119,"twenty":-16.554579,"median":-4.782394,"eighty":-0.817762,"marketCap":493963162},{"date":"2021-09-17","current":-15.440572,"twenty":-16.554579,"median":-4.949865,"eighty":-0.817762,"marketCap":523222304},{"date":"2021-09-24","current":-15.173917,"twenty":-16.554579,"median":-5.094561,"eighty":-0.817762,"marketCap":514186392},{"date":"2021-10-01","current":-14.462838,"twenty":-16.554579,"median":-5.319321,"eighty":-0.817762,"marketCap":490090628},{"date":"2021-10-08","current":-12.862911,"twenty":-16.554579,"median":-5.785203,"eighty":-0.817762,"marketCap":435875159},{"date":"2021-10-15","current":-13.205752,"twenty":-16.554579,"median":-6.107319,"eighty":-0.817762,"marketCap":447492760},{"date":"2021-10-22","current":-14.500932,"twenty":-16.554579,"median":-6.705482,"eighty":-0.817762,"marketCap":491381473},{"date":"2021-10-29","current":-14.221579,"twenty":-16.554579,"median":-7.035014,"eighty":-0.817762,"marketCap":481915280},{"date":"2021-11-05","current":-15.2755,"twenty":-16.554579,"median":-7.331381,"eighty":-0.817762,"marketCap":517628644},{"date":"2021-11-12","current":-15.478665,"twenty":-16.554579,"median":-7.497948,"eighty":-0.817762,"marketCap":524513148},{"date":"2021-11-19","current":-13.942227,"twenty":-16.554579,"median":-7.614194,"eighty":-0.817762,"marketCap":472449087},{"date":"2021-11-26","current":-12.977191,"twenty":-16.554579,"median":-7.668581,"eighty":-0.817762,"marketCap":439747693},{"date":"2021-12-03","current":-10.843954,"twenty":-16.554579,"median":-7.788232,"eighty":-0.827975,"marketCap":367460401},{"date":"2021-12-10","current":-11.237587,"twenty":-16.554579,"median":-7.8854,"eighty":-0.859111,"marketCap":380799127},{"date":"2021-12-17","current":-10.323343,"twenty":-16.554579,"median":-7.988477,"eighty":-0.879153,"marketCap":349818859},{"date":"2021-12-23","current":-9.859358,"twenty":-16.554579,"median":-8.049389,"eighty":-0.891677,"marketCap":361956448},{"date":"2021-12-31","current":-8.363374,"twenty":-16.554579,"median":-8.158065,"eighty":-0.93448,"marketCap":307035935},{"date":"2022-01-07","current":-7.291449,"twenty":-16.554301,"median":-8.158065,"eighty":-0.951103,"marketCap":267683442},{"date":"2022-01-14","current":-7.786183,"twenty":-16.554301,"median":-8.158065,"eighty":-0.96443,"marketCap":285846131},{"date":"2022-01-21","current":-6.643582,"twenty":-16.554301,"median":-8.158065,"eighty":-0.990095,"marketCap":243898968},{"date":"2022-01-28","current":-6.737817,"twenty":-16.554301,"median":-8.158065,"eighty":-1.013469,"marketCap":247358528},{"date":"2022-02-04","current":-6.584685,"twenty":-16.554301,"median":-8.158065,"eighty":-1.027849,"marketCap":241736743},{"date":"2022-02-11","current":-6.501997,"twenty":-16.554301,"median":-8.158065,"eighty":-1.040287,"marketCap":243642404},{"date":"2022-02-18","current":-6.132434,"twenty":-16.554301,"median":-8.158065,"eighty":-1.062721,"marketCap":229794168},{"date":"2022-02-25","current":-6.490448,"twenty":-16.554301,"median":-8.158065,"eighty":-1.085691,"marketCap":243209647},{"date":"2022-03-04","current":-5.728225,"twenty":-16.554301,"median":-8.158065,"eighty":-1.106996,"marketCap":214647660},{"date":"2022-03-11","current":-5.312467,"twenty":-16.554301,"median":-8.158065,"eighty":-1.158225,"marketCap":199068394},{"date":"2022-03-18","current":-5.77442,"twenty":-16.554301,"median":-8.158065,"eighty":-1.189564,"marketCap":216378690},{"date":"2022-03-25","current":-4.619536,"twenty":-16.554301,"median":-8.158065,"eighty":-1.226566,"marketCap":173102952},{"date":"2022-04-01","current":-4.515597,"twenty":-16.554301,"median":-8.158065,"eighty":-1.233418,"marketCap":169208135},{"date":"2022-04-08","current":-4.527145,"twenty":-16.554301,"median":-8.158065,"eighty":-1.247123,"marketCap":169640892},{"date":"2022-04-14","current":-3.811117,"twenty":-16.554301,"median":-8.158065,"eighty":-1.26768,"marketCap":142809935},{"date":"2022-04-22","current":-3.314517,"twenty":-16.554301,"median":-8.158065,"eighty":-1.280014,"marketCap":124201368},{"date":"2022-04-29","current":-3.306011,"twenty":-16.554301,"median":-8.158065,"eighty":-1.300358,"marketCap":123882641},{"date":"2022-05-06","current":-3.525642,"twenty":-16.554301,"median":-8.158065,"eighty":-1.396504,"marketCap":132112607},{"date":"2022-05-13","current":-3.408543,"twenty":-16.554301,"median":-8.158065,"eighty":-1.567315,"marketCap":123048702},{"date":"2022-05-20","current":-3.756599,"twenty":-16.554301,"median":-8.158065,"eighty":-1.692999,"marketCap":135613535},{"date":"2022-05-27","current":-4.188668,"twenty":-16.554301,"median":-8.158065,"eighty":-1.773964,"marketCap":151211257},{"date":"2022-06-03","current":-4.464712,"twenty":-16.554301,"median":-8.158065,"eighty":-1.827608,"marketCap":161176469},{"date":"2022-06-10","current":-4.020641,"twenty":-16.554301,"median":-8.158065,"eighty":-1.879456,"marketCap":145145476},{"date":"2022-06-17","current":-4.716752,"twenty":-16.554301,"median":-8.158065,"eighty":-1.922204,"marketCap":170275141},{"date":"2022-06-24","current":-5.388859,"twenty":-16.554579,"median":-8.158065,"eighty":-1.986916,"marketCap":194538265},{"date":"2022-07-01","current":-4.920909,"twenty":-16.554579,"median":-8.158065,"eighty":-2.104754,"marketCap":177645226},{"date":"2022-07-08","current":-5.545024,"twenty":-16.554579,"median":-8.158065,"eighty":-2.147391,"marketCap":200175840},{"date":"2022-07-15","current":-4.608851,"twenty":-16.554579,"median":-8.158065,"eighty":-2.267774,"marketCap":166379919},{"date":"2022-07-22","current":-4.584847,"twenty":-16.554579,"median":-8.158065,"eighty":-2.342744,"marketCap":165513357},{"date":"2022-07-29","current":-4.596849,"twenty":-16.554579,"median":-8.158065,"eighty":-2.385632,"marketCap":165946638},{"date":"2022-08-05","current":-5.052933,"twenty":-16.554579,"median":-8.158065,"eighty":-2.441697,"marketCap":182411317},{"date":"2022-08-12","current":-4.922494,"twenty":-16.554579,"median":-8.158065,"eighty":-2.459289,"marketCap":180842316},{"date":"2022-08-19","current":-5.170389,"twenty":-16.554579,"median":-8.158065,"eighty":-2.496095,"marketCap":189949483},{"date":"2022-08-26","current":-4.62738,"twenty":-16.554579,"median":-8.158065,"eighty":-2.52589,"marketCap":170000451},{"date":"2022-09-02","current":-4.532944,"twenty":-16.554579,"median":-8.158065,"eighty":-2.565239,"marketCap":166531054},{"date":"2022-09-09","current":-4.957907,"twenty":-16.554579,"median":-8.158065,"eighty":-2.577527,"marketCap":182143340},{"date":"2022-09-16","current":-4.875276,"twenty":-16.554579,"median":-8.158065,"eighty":-2.615174,"marketCap":179107618},{"date":"2022-09-23","current":-4.131589,"twenty":-16.554579,"median":-8.158065,"eighty":-2.629256,"marketCap":151786117},{"date":"2022-09-30","current":-3.647603,"twenty":-16.554579,"median":-8.158065,"eighty":-2.650331,"marketCap":134005457},{"date":"2022-10-07","current":-3.989935,"twenty":-16.554579,"median":-8.158065,"eighty":-2.709192,"marketCap":146582021},{"date":"2022-10-14","current":-3.730235,"twenty":-16.554579,"median":-8.158065,"eighty":-2.97036,"marketCap":137041179},{"date":"2022-10-21","current":-3.541362,"twenty":-16.554579,"median":-8.158065,"eighty":-3.086022,"marketCap":130102386},{"date":"2022-10-28","current":-4.10798,"twenty":-16.554579,"median":-8.158065,"eighty":-3.173453,"marketCap":150918767},{"date":"2022-11-04","current":-4.084371,"twenty":-16.554579,"median":-8.158065,"eighty":-3.238566,"marketCap":150051418},{"date":"2022-11-11","current":-3.97813,"twenty":-16.554579,"median":-8.158065,"eighty":-3.306011,"marketCap":146148346},{"date":"2022-11-18","current":-3.505949,"twenty":-16.554579,"median":-8.158065,"eighty":-3.349291,"marketCap":128801362},{"date":"2022-11-25","current":-3.564971,"twenty":-16.554579,"median":-8.158065,"eighty":-3.375176,"marketCap":130969735},{"date":"2022-12-02","current":-3.423317,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":125765639},{"date":"2022-12-09","current":-2.821285,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":103648234},{"date":"2022-12-16","current":-2.455345,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":90204320},{"date":"2022-12-23","current":-2.70324,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":99311487},{"date":"2022-12-30","current":-2.727829,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":102647678},{"date":"2023-01-06","current":-2.890338,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":108762858},{"date":"2023-01-13","current":-3.319826,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":124924408},{"date":"2023-01-20","current":-3.296611,"twenty":-16.554579,"median":-8.158065,"eighty":-3.423904,"marketCap":124050810},{"date":"2023-01-27","current":-3.180533,"twenty":-16.554579,"median":-8.158065,"eighty":-3.423904,"marketCap":119682824},{"date":"2023-02-03","current":-3.110886,"twenty":-16.554579,"median":-8.158065,"eighty":-3.423904,"marketCap":117062032},{"date":"2023-02-10","current":-3.238572,"twenty":-16.554579,"median":-8.158065,"eighty":-3.423904,"marketCap":121866817},{"date":"2023-02-17","current":-3.60613,"twenty":-16.554579,"median":-8.158065,"eighty":-3.425791,"marketCap":132966149},{"date":"2023-02-24","current":-3.096052,"twenty":-16.554579,"median":-8.158065,"eighty":-3.427633,"marketCap":114158437},{"date":"2023-03-03","current":-3.511232,"twenty":-16.554579,"median":-8.158065,"eighty":-3.434617,"marketCap":129467040},{"date":"2023-03-10","current":-2.799496,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":103223721},{"date":"2023-03-17","current":-2.633424,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":97100280},{"date":"2023-03-24","current":-2.680873,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":98849834},{"date":"2023-03-31","current":-2.752046,"twenty":-16.554301,"median":-8.158065,"eighty":-3.436757,"marketCap":101474166},{"date":"2023-04-06","current":-2.704597,"twenty":-16.554301,"median":-8.158065,"eighty":-3.436757,"marketCap":99724612},{"date":"2023-04-14","current":-2.884201,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":106347001},{"date":"2023-04-21","current":-3.109715,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":114662198},{"date":"2023-04-28","current":-2.528127,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":93217741},{"date":"2023-05-05","current":-2.885438,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":106392623},{"date":"2023-05-12","current":-3.28552,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":121144541},{"date":"2023-05-19","current":-3.220882,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":113992096},{"date":"2023-05-26","current":-2.969054,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":105079495},{"date":"2023-06-02","current":-3.04486,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":107762376},{"date":"2023-06-09","current":-3.221739,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":114022431},{"date":"2023-06-16","current":-3.04486,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":107762376},{"date":"2023-06-23","current":-2.842711,"twenty":-16.554858,"median":-8.158065,"eighty":-3.438897,"marketCap":100608027},{"date":"2023-06-30","current":-3.006957,"twenty":-16.555136,"median":-8.158065,"eighty":-3.445225,"marketCap":106420936},{"date":"2023-07-07","current":-3.095397,"twenty":-16.555136,"median":-8.158065,"eighty":-3.445225,"marketCap":109550963},{"date":"2023-07-14","current":-2.95642,"twenty":-16.555136,"median":-8.158065,"eighty":-3.445225,"marketCap":104632348},{"date":"2023-07-21","current":-2.63008,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":93082691},{"date":"2023-07-28","current":-2.282963,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":80797665},{"date":"2023-08-04","current":-2.096054,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":74182652},{"date":"2023-08-11","current":-1.895794,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":67095137},{"date":"2023-08-18","current":-1.746139,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":59075121},{"date":"2023-08-25","current":-1.899799,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":64273731},{"date":"2023-09-01","current":-1.941706,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":65691534},{"date":"2023-09-08","current":-1.788046,"twenty":-16.555136,"median":-8.158065,"eighty":-3.438897,"marketCap":60492924},{"date":"2023-09-15","current":-1.732169,"twenty":-16.555136,"median":-8.158065,"eighty":-3.424794,"marketCap":58602520},{"date":"2023-09-22","current":-1.704231,"twenty":-16.555136,"median":-8.158065,"eighty":-3.408904,"marketCap":57657318},{"date":"2023-09-29","current":-1.690262,"twenty":-16.555136,"median":-8.158065,"eighty":-3.359935,"marketCap":57184717},{"date":"2023-10-06","current":-1.522633,"twenty":-16.555136,"median":-8.158065,"eighty":-3.340953,"marketCap":51513505},{"date":"2023-10-13","current":-1.648355,"twenty":-16.555136,"median":-8.158065,"eighty":-3.323464,"marketCap":55766914},{"date":"2023-10-20","current":-1.578509,"twenty":-16.555136,"median":-8.158065,"eighty":-3.306452,"marketCap":53403909},{"date":"2023-10-27","current":-1.88583,"twenty":-16.555414,"median":-8.188189,"eighty":-3.305529,"marketCap":63801130},{"date":"2023-11-03","current":-2.584285,"twenty":-16.555414,"median":-8.188189,"eighty":-3.27978,"marketCap":87431179},{"date":"2023-11-10","current":-3.338617,"twenty":-16.555414,"median":-8.188189,"eighty":-3.268215,"marketCap":112951631},{"date":"2023-11-17","current":-3.115111,"twenty":-16.555414,"median":-8.188189,"eighty":-3.261184,"marketCap":105390016},{"date":"2023-11-24","current":-3.72287,"twenty":-16.555414,"median":-8.188189,"eighty":-3.259721,"marketCap":125951626},{"date":"2023-12-01","current":-3.323991,"twenty":-16.555414,"median":-8.188189,"eighty":-3.259721,"marketCap":112456809},{"date":"2023-12-08","current":-3.841056,"twenty":-16.555414,"median":-8.181747,"eighty":-3.259642,"marketCap":129950090},{"date":"2023-12-15","current":-4.180842,"twenty":-16.555414,"median":-8.181747,"eighty":-3.259642,"marketCap":141445675},{"date":"2023-12-22","current":-4.123134,"twenty":-16.555414,"median":-8.181747,"eighty":-3.267442,"marketCap":133448746},{"date":"2023-12-29","current":-4.385655,"twenty":-16.555414,"median":-8.188189,"eighty":-3.27978,"marketCap":141945483},{"date":"2024-01-05","current":-3.72163,"twenty":-16.555414,"median":-8.194631,"eighty":-3.300075,"marketCap":120453737},{"date":"2024-01-12","current":-3.798842,"twenty":-16.555414,"median":-8.194631,"eighty":-3.310738,"marketCap":122952777},{"date":"2024-01-19","current":-3.690745,"twenty":-16.555414,"median":-8.203542,"eighty":-3.323991,"marketCap":119454121},{"date":"2024-01-26","current":-4.138576,"twenty":-16.555414,"median":-8.194631,"eighty":-3.334233,"marketCap":133948554},{"date":"2024-02-02","current":-4.231231,"twenty":-16.555414,"median":-8.194631,"eighty":-3.34328,"marketCap":136947402},{"date":"2024-02-09","current":-4.401098,"twenty":-16.555414,"median":-8.194631,"eighty":-3.378353,"marketCap":142445291},{"date":"2024-02-16","current":-4.102727,"twenty":-16.555414,"median":-8.194631,"eighty":-3.410709,"marketCap":127390985},{"date":"2024-02-23","current":-3.755038,"twenty":-16.555414,"median":-8.194631,"eighty":-3.422786,"marketCap":116595138},{"date":"2024-03-01","current":-3.615963,"twenty":-16.555414,"median":-8.188189,"eighty":-3.428196,"marketCap":112276800},{"date":"2024-03-08","current":-3.963652,"twenty":-16.555414,"median":-8.188189,"eighty":-3.470535,"marketCap":123072646},{"date":"2024-03-15","current":-3.668116,"twenty":-16.555414,"median":-8.188189,"eighty":-3.470535,"marketCap":113896177},{"date":"2024-03-22","current":-3.285659,"twenty":-16.555414,"median":-8.188189,"eighty":-3.459169,"marketCap":102020746},{"date":"2024-03-28","current":-3.285659,"twenty":-16.555414,"median":-8.188189,"eighty":-3.423904,"marketCap":102020746},{"date":"2024-04-05","current":-3.024892,"twenty":-16.555414,"median":-8.194631,"eighty":-3.397101,"marketCap":93923861},{"date":"2024-04-12","current":-2.885817,"twenty":-16.555414,"median":-8.194631,"eighty":-3.339444,"marketCap":89605523},{"date":"2024-04-19","current":-2.607666,"twenty":-16.555414,"median":-8.194631,"eighty":-3.324821,"marketCap":80968846},{"date":"2024-04-26","current":-2.520743,"twenty":-16.555414,"median":-8.158065,"eighty":-3.320187,"marketCap":78269884},{"date":"2024-05-03","current":-2.572897,"twenty":-16.555414,"median":-8.063626,"eighty":-3.305715,"marketCap":79889261},{"date":"2024-05-10","current":-2.62505,"twenty":-16.555414,"median":-7.973149,"eighty":-3.284927,"marketCap":81508638},{"date":"2024-05-17","current":-2.523034,"twenty":-16.555414,"median":-7.880326,"eighty":-3.268572,"marketCap":75570923},{"date":"2024-05-24","current":-2.288752,"twenty":-16.555414,"median":-7.880326,"eighty":-3.257706,"marketCap":68553623},{"date":"2024-05-31","current":-2.180622,"twenty":-16.555414,"median":-7.880326,"eighty":-3.236893,"marketCap":65314869},{"date":"2024-06-07","current":-2.314496,"twenty":-16.555414,"median":-7.880326,"eighty":-3.221739,"marketCap":69324719},{"date":"2024-06-14","current":-2.332578,"twenty":-16.555414,"median":-7.8854,"eighty":-3.215662,"marketCap":69866318},{"date":"2024-06-21","current":-2.224086,"twenty":-16.555414,"median":-7.793671,"eighty":-3.181352,"marketCap":66616722},{"date":"2024-06-28","current":-2.133676,"twenty":-16.56918,"median":-7.730784,"eighty":-3.173129,"marketCap":63908725},{"date":"2024-07-05","current":-1.98902,"twenty":-16.56918,"median":-7.646826,"eighty":-3.154082,"marketCap":59575930},{"date":"2024-07-12","current":-2.242168,"twenty":-16.56918,"median":-7.50542,"eighty":-3.134102,"marketCap":67158321},{"date":"2024-07-15","current":-2.314496,"twenty":-16.56918,"median":-7.491698,"eighty":-3.128727,"marketCap":69324719},{"date":"2024-08-02","current":-2.688567,"twenty":-16.607352,"median":-7.295099,"eighty":-3.110886,"marketCap":80529027},{"date":"2024-08-09","current":-2.323015,"twenty":-16.607352,"median":-7.150096,"eighty":-3.099278,"marketCap":69579874},{"date":"2024-08-16","current":-2.27142,"twenty":-16.607352,"median":-6.843832,"eighty":-3.09443,"marketCap":66100881},{"date":"2024-08-23","current":-2.345527,"twenty":-16.607352,"median":-6.688854,"eighty":-3.070128,"marketCap":68257484},{"date":"2024-08-30","current":-2.292699,"twenty":-16.607352,"median":-6.596464,"eighty":-3.04486,"marketCap":66720153},{"date":"2024-09-06","current":-2.303265,"twenty":-16.607352,"median":-6.46689,"eighty":-3.041239,"marketCap":67027619},{"date":"2024-09-13","current":-2.535705,"twenty":-16.607352,"median":-6.274951,"eighty":-3.024892,"marketCap":73791874},{"date":"2024-09-20","current":-2.324396,"twenty":-16.607352,"median":-6.057367,"eighty":-2.994322,"marketCap":67642551},{"date":"2024-09-27","current":-2.218741,"twenty":-16.607352,"median":-5.699353,"eighty":-2.972739,"marketCap":64567890},{"date":"2024-10-04","current":-2.303265,"twenty":-16.607352,"median":-5.568012,"eighty":-2.95642,"marketCap":67027619},{"date":"2024-10-11","current":-2.134218,"twenty":-16.607352,"median":-5.39486,"eighty":-2.919808,"marketCap":62108161},{"date":"2024-10-18","current":-2.007433,"twenty":-16.607352,"median":-5.332349,"eighty":-2.918118,"marketCap":58418567},{"date":"2024-10-25","current":-1.91171,"twenty":-16.607352,"median":-5.243092,"eighty":-2.890338,"marketCap":55632924},{"date":"2024-10-31","current":-1.897341,"twenty":-16.607352,"median":-5.044113,"eighty":-2.883743,"marketCap":55214770},{"date":"2024-11-08","current":-1.478527,"twenty":-16.609949,"median":-4.981516,"eighty":-2.848594,"marketCap":43026812},{"date":"2024-11-15","current":-1.18354,"twenty":-16.609949,"median":-4.934298,"eighty":-2.836112,"marketCap":34442357},{"date":"2024-11-22","current":-1.277361,"twenty":-16.609949,"median":-4.898885,"eighty":-2.816927,"marketCap":37172656},{"date":"2024-11-29","current":-1.391679,"twenty":-16.609949,"median":-4.828057,"eighty":-2.773442,"marketCap":40499440},{"date":"2024-12-06","current":-1.228732,"twenty":-16.609949,"median":-4.756274,"eighty":-2.752046,"marketCap":35757501},{"date":"2024-12-13","current":-1.616384,"twenty":-16.609949,"median":-4.688829,"eighty":-2.728223,"marketCap":47038597},{"date":"2024-12-20","current":-1.677557,"twenty":-16.609949,"median":-4.668862,"eighty":-2.705881,"marketCap":48818815},{"date":"2024-12-27","current":-1.545563,"twenty":-16.609949,"median":-4.632739,"eighty":-2.704326,"marketCap":44977627},{"date":"2025-01-03","current":-0.909709,"twenty":-16.609949,"median":-4.608851,"eighty":-2.687028,"marketCap":26473567},{"date":"2025-01-10","current":-0.803368,"twenty":-16.612546,"median":-4.588407,"eighty":-2.645781,"marketCap":23378922},{"date":"2025-01-17","current":-1.07211,"twenty":-16.612546,"median":-4.535819,"eighty":-2.62505,"marketCap":29568709},{"date":"2025-01-24","current":-1.05142,"twenty":-16.56918,"median":-4.511084,"eighty":-2.607666,"marketCap":28998085},{"date":"2025-01-31","current":-1.073453,"twenty":-16.521638,"median":-4.464712,"eighty":-2.573626,"marketCap":29605762},{"date":"2025-02-07","current":-1.056257,"twenty":-16.393722,"median":-4.436345,"eighty":-2.54602,"marketCap":29131477},{"date":"2025-02-14","current":-1.088501,"twenty":-16.278983,"median":-4.396899,"eighty":-2.522118,"marketCap":30020762},{"date":"2025-02-21","current":-1.168806,"twenty":-16.266724,"median":-4.365891,"eighty":-2.492369,"marketCap":32660481},{"date":"2025-02-28","current":-0.910729,"twenty":-16.242394,"median":-4.296201,"eighty":-2.463292,"marketCap":25448923},{"date":"2025-03-07","current":-0.94361,"twenty":-16.23404,"median":-4.238424,"eighty":-2.421882,"marketCap":26367741},{"date":"2025-03-14","current":-0.834467,"twenty":-16.223526,"median":-4.180842,"eighty":-2.404906,"marketCap":23317885},{"date":"2025-03-21","current":-0.750191,"twenty":-16.223526,"median":-4.154019,"eighty":-2.366658,"marketCap":20962933},{"date":"2025-03-28","current":-0.660113,"twenty":-16.210733,"median":-4.131589,"eighty":-2.354732,"marketCap":18445837},{"date":"2025-04-04","current":-0.549587,"twenty":-16.210733,"median":-4.10798,"eighty":-2.345527,"marketCap":15357375},{"date":"2025-04-11","current":-0.582745,"twenty":-16.20979,"median":-4.099451,"eighty":-2.323015,"marketCap":16283913},{"date":"2025-04-17","current":-0.711507,"twenty":-16.20979,"median":-4.08831,"eighty":-2.314496,"marketCap":19881971},{"date":"2025-04-23","current":-0.821869,"twenty":-16.210733,"median":-4.072567,"eighty":-2.303265,"marketCap":22965863}],"updateTime":1745556004911}}}